Prime Medicine, Inc. (PRME)

4.235 +0.34 (+8.59%) USD  |  NASDAQ  |  Nov 11, 13:14
More

Prime Medicine Total Expenses (% of Annual Revenues)

Total Expenses (% of Annual Revenues) Chart

View Total Expenses (% of Annual Revenues) for PRME.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Total Expenses (% of Annual Revenues) Data

View and export this data back to 2020. Start Trial.
Date Value
December 31, 2025 --
December 31, 2024 --
Date Value
December 31, 2020 --

Total Expenses (% of Annual Revenues) Range, Past 5 Years

View Total Expenses (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (% of Annual Revenues) Benchmarks

View Total Expenses (% of Annual Revenues) Benchmarks
Start Trial
Intellia Therapeutics, Inc. Upgrade
Beam Therapeutics, Inc. Upgrade
Twist Bioscience Corp. Upgrade
Moderna, Inc. Upgrade
Q32 Bio, Inc. Upgrade